Feb 2, 2023, 01:00 AM by User Not Found

Bio-IT World | Researchers in Germany have developed a series of innovative solutions for probing the body more broadly and deeply for early pathological signs of diseases ranging from metabolic disorders and neurodegenerative diseases to cancer. Their novel technology, dubbed DISCO-MS, does spatial proteomics in three-dimensional (3D) intact specimens using a combination of whole-organ and whole-organism clearing and imaging, deep-learning-based image analysis, robotic tissue extraction, and ultrahigh-sensitivity mass spectrometry.

Feb 1, 2023, 10:20 AM by

MURAL HEALTH, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance and LEDGER RUN, an innovative technology company focused on optimizing clinical operations, today announced a strategic partnership. Through this partnership, Mural Health’s Mural Link™ platform and Ledger Run’s unique ClinRun™ platform work together to improve clinical operations and materially improve the efficiency, and outcomes, of global clinical trials.

Feb 1, 2023, 10:16 AM by

Schedule a Time to Meet us at the Event Book Your Slot Now Clinion is thrilled to be a part of this prestigious conference and looks forward to networking with some of the top minds in the field. We hope

Feb 1, 2023, 10:14 AM by

Linus Health began a partnership with Health Innovation Manchester (HIM) to bring digitalized cognitive screening tools into primary care at four pilot sites. This initiative will empower doctors to identify cognitive impairment early and minimize dementia risks.

Jan 31, 2023, 10:28 AM by

Novel AAV Capsid Anc80 enables efficient gene transfer

Jan 31, 2023, 10:19 AM by

New and Expanded Agreements with Major Healthcare Organizations Underscore ZeOmega as Go-to Resource for Population Health Management

Jan 31, 2023, 10:15 AM by

Former Loxo@Lily exec Bree Harlin has been appointed CCO by TC BioPharm to oversee expansion of U.S. FDA clinical Trials.

Jan 31, 2023, 01:00 AM by User Not Found

Bio-IT World | A new study published in the Proceedings of the National Academy of Science demonstrates the potential for lab-grown retinal neurons to reestablish synaptic function and cure neurodegenerative eye disease, according to researchers from the University of Wisconsin–Madison.

Jan 30, 2023, 10:30 AM by

Verisense® Health, Inc. launched today as a digital health software and data management company. It was established with the goal of providing sponsors with cost-efficient access to a digital biobank of longitudinal raw patient data. The new company is a spin-off from Dublin-based wearable technology services and sensor manufacturer Shimmer Research.

Jan 30, 2023, 10:28 AM by

Jan 30, 2023, 10:28 AM by

Jan 30, 2023, 10:27 AM by

Jan 30, 2023, 10:27 AM by

A recent market report reveals the huge potential of exosome research, which is gaining mounting research fever across the industry.

Jan 30, 2023, 10:26 AM by

Jan 30, 2023, 10:22 AM by

Jan 30, 2023, 10:21 AM by

Jan 30, 2023, 10:21 AM by

Jan 30, 2023, 10:21 AM by

Jan 30, 2023, 10:11 AM by

About Huateng Pharma Huateng Pharma is a leading and professional manufacturer which can provide APIs, pharmaceutical intermediates, PEG derivatives, biochemical reagents, Vitamin D Derivatives and so on. We have established a 5000 square meters R&D center and have our own manufacturing site covering 34,000 square meters. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818

Jan 27, 2023, 09:49 AM by